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OBJECTIVES The aim of this study was to investigate the prognostic value of carbon-11–acetate (acetate)
positron emission tomography (PET) after successful reperfusion of myocardial infarction
(MI).
BACKGROUND Acetate PET allows the measurement of both myocardial flow and oxidative metabolism. The
prognostic value of acetate measurements performed early (within 24 h) after Thrombolysis
In Myocardial Infarction (TIMI) flow grade 3 reperfused MI is unknown.
METHODS In 18 patients with TIMI flow grade 3 reperfusion of their first MI, a dynamic acetate study
was performed within 24 h of the acute event. At five days, nitrogen-13–NH3 (NH3) and
fluorine-18–labeled fluorodeoxyglucose (FDG) PET studies were performed. Infarct-related
areas were classified as “PET viable” or “PET nonviable,” as assessed with NH3 and FDG,
according to previously established criteria. At five days and three months, radionuclide
angiography was performed for evaluation of left ventricular (LV) function.
RESULTS In infarct-related regions, myocardial blood flow, FDG uptake and oxygen consumption were
decreased, compared with remote regions. However, oxygen consumption values, as measured
with acetate in both PET-viable and PET-nonviable areas, as assessed with NH3 and FDG,
were not significantly different (p 5 NS). A significant linear correlation was observed
between global LV ejection fraction at three months and oxidative metabolism in the
infarct-related area (r 5 0.8, p , 0.0001). Multivariate analysis revealed that oxidative
metabolism measurements in reperfused myocardium was the only significant predictor for
recovery of LV function at three months (p , 0.05).
CONCLUSIONS Measurement of oxidative metabolism early after TIMI flow grade 3 reperfusion of MI offers
important prognostic value concerning LV function at follow-up. (J Am Coll Cardiol 2001;
37:30–6) © 2001 by the American College of Cardiology
Several studies have investigated the possible use of acetate
as a tracer of both regional myocardial perfusion (due to its
high first-pass extraction fraction in the myocardium) and
regional myocardial oxygen consumption (1–4). Acetate is
extracted by myocytes and converted to carbon-11–acetyl
coenzyme A within the mitochondria, which then enters the
tricarboxylic acid cycle. Carbon-11 activity is cleared in the
form of carbon dioxide. Initial high uptake of acetate
depends on myocardial blood flow, suggesting that early
images may be useful to study myocardial blood flow (2).
Studies in isolated, perfused rat hearts have demonstrated
biexponential carbon dioxide clearance (5). Both the slope
of the rapid clearance phase of this biexponential decrease
and the decay constant of a restricted monoexponential fit
correlate linearly with myocardial oxygen consumption un-
der varying work load conditions (5,6). More recently,
different compartment models, based on the biochemical
transport steps of acetate, were presented (7,8).
In a previous study measuring myocardial tissue flow in
patients with infarcts shortly after successful thrombolysis,
recovery of left ventricular (LV) contractile function at
follow-up was highly dependent on the absence or presence
of adequate myocardial tissue reperfusion (9). The aim of
the underlying study was to investigate the predictive value
of acetate perfusion and oxidative metabolism measure-
ments for the restoration of LV function in the acute stage
of Thrombolysis In Myocardial Infarction (TIMI) flow
grade 3 reperfused myocardial infarction (MI).
METHODS
Patients with a first acute MI of ,6 h duration with one- or
two-vessel disease and TIMI flow grade 3 reperfusion at
90 min were prospectively and consecutively included. Only
patients with typical chest pain of .30 min and with ST
segment elevation of .0.1 mV in two or more limb leads or
.0.2 mV in two or more contiguous precordial leads were
enrolled. Patients received thrombolytic therapy according
to the Global Utilization of Streptokinase and t-PA for
Occluded Coronary Arteries (GUSTO) protocol (10,11).
All patients underwent coronary angiography at 90 min
after the start of thrombolytic therapy. A control angiogram
was obtained at five days. The angiograms were read by two
independent, experienced angiographers. The patency of
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the infarct-related vessel was scored according to the TIMI
criteria of reperfusion (12). In all patients, positron emission
tomographic (PET) acetate (within 24 h), ammonia (NH3)
and fluoine-18–fluorodeoxyglucose (FDG) (at five days)
measurements were performed. Radionuclide angiography
was performed both at five days and three months. In
addition, an acetate scan was performed in 10 normal
volunteers. The study was approved by the Ethical Com-
mittee for Human Research of the University of Leuven.
Positron emission tomography. The acetate and NH3/
FDG studies were performed with a whole-body PET
scanner (model 931-08/12, CTI Siemens, Knoxville, Ten-
nessee). A cyclotron (cyclone 10/5, Ion Beam Applications,
Louvain la Neuve, Belgium) and chemical processing equip-
ment were used to produce acetate, NH3 and FDG. Before
each study, a rectilinear scan (2 min) was obtained to
position the heart within the field of view. A transmission
scan (15 min) using a germanium-68 ring source was
performed for photon attenuation correction. Finally, an
emission scan was acquired after injection of the tracer
(acetate, NH3 or FDG).
Image acquisition. NH3/FDG. Five days after the acute MI,
myocardial blood flow and metabolism were measured with
NH3 and FDG.
Myocardial perfusion was evaluated using NH3: 740
MBq of NH3 in 5 ml saline followed by a 20-ml flush of
saline was slowly infused at a constant rate of 10 ml/min.
Acquisition was started simultaneously with the injection of
NH3. In each patient, 20 dynamic frames were recorded
(12 3 10 s, 4 3 30 s, 3 3 2 min, 1 3 10 min). Regional
myocardial utilization of exogenous glucose was evaluated
with FDG. The metabolic studies were performed using the
euglycemic hyperinsulinemic clamp technique (13,14). The
tracer dose of 370 MBq was injected after stabilization of
the glucose level between 85 and 95 mg% and not earlier
than 50 min after NH3 injection to allow isotope decay. In
each patient, four frames were recorded starting 30 min after
injection of FDG (4 3 10 min). The time required for
image acquisition of the combined NH3 and FDG study
was 21
2
to 3 h.
ACETATE. In each subject, a dynamic acetate study was
performed within 24 h after the onset of symptoms. The
tracer dose of 740 MBq of acetate, diluted with 0.9% saline
to a volume of 5 ml was injected in a bolus. In each patient,
22 dynamic frames were recorded (8 3 30 s, 6 3 60 s, 8 3
120 s). Total acquisition time was 26 min.
Data analysis. NH3/FDG. The frames of the perfusion stud-
ies were reconstructed using a Hanning filter with a cut-off
frequency of 0.3. A summed frame was constructed using
frames 18 to 20. The long axis of the LV was indicated
manually on the summed frame. The myocardial image was
resampled into 16 radial slices. The radial slices were
delineated using an algorithm developed in our department
(15,16). The delineation was used to construct a polar map
(17). In the patients with MI, two regions of interest
(remote and infarct-related regions) were defined on the
polar map of the NH3 study. The first, representing remote
myocardium, was defined as the perfusion territory of a
non-infarct-related artery (according to electrocardio-
graphic findings) without significant coronary artery steno-
sis (according to angiographic findings). This region was
manually drawn on the basis of previously established
criteria, depending on the coronary anatomy as seen on the
angiogram (18). Finally, the remote region was automati-
cally copied to the other polar maps (FDG and acetate).
The same procedure was followed to define the infarct-
related region: the territory of the infarct-related artery was
defined on the NH3 polar map, depending on the coronary
anatomy as seen on the angiogram (18). The infarct region
was manually drawn within the territory of the infarct-
related artery, on the basis of a simple visual estimation of
the infarct zone. The infarct region was automatically
copied to the other polar maps. A flow index was calculated
as the ratio of the averaged counts in the infarct region
divided by the counts in the remote area.
The frames of the metabolic study were reconstructed
using a Hanning 0.4 filter. A summed frame was con-
structed. The creation of radial slices, delineation maps,
polar maps and regional time-activity curves was done in
exactly the same way as for the flow studies. The remote and
infarct regions for FDG were the same as for NH3. A
metabolic index was defined as the ratio of the averaged
counts in the infarct region to that in the remote region.
On the basis of values obtained in normal volunteers, the
myocardium was supposed to demonstrate a “PET-viable”
pattern if the flow index was .0.8 or if the ratio of the
metabolic and flow indexes was .1.2 (19,20).
ACETATE. Polar maps of every frame were constructed in
the same way as for the NH3 and FDG images. In normal
subjects, a single region enclosing the entire polar map was
drawn. For patient studies, we used the same two regions as
defined in the analysis of the NH3 and FDG images.
Absolute blood flow (ml/min per g) and oxidative metabo-
lism (1/min) were calculated using a three-compartment
model (7). In this model, rate constant K1 estimates the
product of blood flow and first-pass extraction fraction
(herein simply called blood flow); rate constant k2 is pro-
portional to the oxygen consumption. For linear regression
analysis, acetate perfusion and metabolic indexes were used.
Abbreviations and Acronyms
C-11 5 carbon-11
FDG 5 fluorine-18–fluorodeoxyglucose
LV 5 left ventricular
MI 5 myocardial infarction
N-13–NH3 5 nitrogen-13–ammonia
PET 5 positron emission tomography
TIMI 5 Thrombolysis In Myocardial Infarction
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The acetate perfusion index was defined as the ratio of blood
flow in the infarct region to that in the remote region. The
acetate metabolic index was defined as the ratio of oxidative
metabolism in the infarct region to that in the remote
region.
Radionuclide angiography. Radionuclide angiography
was performed at five days and three months. Red blood
cells were labeled with 740 MBq of technetium-99m. Ten
minutes after the injection, an equilibrium-gated nuclear
angiogram was acquired during 10 min. A low energy,
all-purpose collimator was used. Global ejection fractions
were calculated automatically using standard software
(Sopha Medical Benelux, Brussels, Belgium). The studies
were interpreted by a skilled nuclear medicine physician.
Function was considered to have improved if the ejection
fraction was 5% higher (ejection fraction units) at three
months compared with five days. Ejection fractions $50%
were considered to be normal. The software was validated
with 88 gated, blood pool data sets from the Mayo Clinic
(Rochester, Minnesota).
Statistical analysis. Results are given as the mean value 6
SD. To test the hypothesis that the vector mean values from
two multivariate groups were equal, multivariate analysis of
variance was applied. If the null hypothesis was rejected,
simultaneous confidence intervals for the differences be-
tween the mean values were computed to identify which of
the components were significantly different. For evaluation
of the relation between flow measurements with acetate and
those with NH3 and for evaluation of measurements of
oxidative metabolism and FDG uptake, linear regression
plots were used. Statistical significance was indicated at p ,
0.05.
RESULTS
Clinical characteristics. Eighteen patients were prospec-
tively included in the study protocol (17 men and 1 woman,
mean age 54 6 14 years). Three patients were excluded
because C-11–acetate scan could not be scheduled within
24 h. Patients received both an acetate scan at 24 h and a
NH3/FDG scan at five days after the infarction. Before
admission, the patients’ cardiac medications included the
following: nitrates (n 5 5), angiotensin-converting enzyme
inhibitors (n 5 1), aspirin (n 5 5), beta-blockers (n 5 4),
calcium channel antagonists (n 5 1) and diuretics (n 5 1).
The infarct-related coronary artery was the left anterior
descending coronary artery in eight patients, the right
coronary artery in five patients and the left circumflex
coronary artery in five patients. All patients with infarcts
were medically treated with recombinant staphylokinase or
front-loaded alteplase with intravenous heparin, or strep-
tokinase with intravenous or subcutaneous heparin (10,11).
Oral aspirin was given to every patient. The mean blood
pressure at the time of the acetate scan was 118/78 mm Hg.
The mean heart rate was 79 6 24 beats/min.
In addition, an acetate scan was also performed in 10
male volunteers (mean age 37 6 12 years, mean blood
pressure 124/82 mm Hg, mean heart rate 72 6 16 beats/
min). The volunteers were selected on the basis of the
absence of a cardiac history, with a normal clinical investi-
gation, a normal rest electrocardiogram and a normal bicycle
stress test. None of the volunteers was taking a cardiac
medication.
Myocardial blood flow and metabolism (Table 1). The
NH3 flow index values in the infarct area were 0.65 6 0.14.
Blood flow values measured with acetate in the infarct area
Table 1. Ejection Fraction, Acetate Flow and Metabolic Index, Ammonia Perfusion Index, Fluorine-18–flurodeoxyglucose Metabolic
Index and Mismatch Index for Each Patient
Pt.
No.
EF at
5 Days
(%)
EF at
3 Months
(%)
DEF
(%)
Infarct
Extent*
(%)
Acetate
Perfusion
Index
Acetate
Metabolic
Index
NH3
Perfusion
Index
FDG
Metabolic
Index
Mismatch
Index
1 22 44 22 27 0.60 0.69 0.67 0.91 1.36
2 60 59 21 30 0.42 0.91 0.58 0.58 1.00
3 46 57 11 41 0.53 0.89 0.59 0.48 0.81
4 39 33 26 30 0.23 0.66 0.36 0.32 0.89
5 40 43 3 15 0.80 0.68 0.86 0.58 0.67
6 39 41 2 12 0.60 0.60 0.70 0.49 0.70
7 36 28 28 15 0.43 0.31 0.62 0.59 0.95
8 59 53 26 12 0.54 0.69 0.61 0.65 1.07
9 63 56 27 35 0.77 0.89 0.89 0.75 0.84
10 55 58 3 17 0.94 1.07 0.69 0.76 1.10
11 47 50 3 34 0.45 0.69 0.55 0.46 0.84
12 39 32 27 15 0.42 0.53 0.64 0.39 0.61
13 44 50 6 34 0.45 0.81 0.53 0.51 0.96
14 54 61 7 11 0.68 0.93 0.68 0.49 0.72
15 64 69 5 10 0.85 0.80 0.76 1.23 1.62
16 61 61 0 14 0.80 0.81 0.90 0.69 0.77
17 16 39 23 29 0.54 0.74 0.46 0.49 1.07
18 — — — 39 0.49 1.31 0.70 0.45 0.64
*Extent of infarction left ventricle.
DEF 5 change in ejection fraction (EF); between five days and three months; FDG 5 fluorine-18–flurodeoxyglucose; NH3 5 ammonia.
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revealed significantly decreased flow, compared with those
values in remote myocardium (0.46 6 0.11 vs. 0.83 6 0.18
ml/g per min, p , 0.001). Moreover, the patients’ blood
flow in remote areas, as measured with acetate, was signif-
icantly higher than that in normal volunteers (0.83 6 0.18
vs. 0.64 6 0.1 ml/g per min, p , 0.05). Linear regression
analysis of the infarct regions revealed a linear relationship
between NH3 flow index values and acetate perfusion index
values (r 5 0.76, p , 0.001).
The FDG metabolic index values in the infarct area were
0.6 6 0.21. Myocardial oxygen consumption measurements
with acetate (as estimated by k2) in the infarct area (0.075 6
0.02/min) were significantly lower than those values in both
remote areas of patients (0.099 6 0.03/min) and in normal
volunteers (0.095 6 0.03/min) (p , 0.05). A poor, though
statistically significant, linear correlation was observed be-
tween FDG metabolic index values and acetate metabolic
index values (r 5 0.5, p , 0.05). A statistically significant
linear relationship was found between FDG metabolic
index values and NH3 flow index values (r 5 0.8, p , 0.01).
Evaluation of PET-viable and PET-nonviable regions as
assessed with NH3 and FDG. In total, 18 infarct regions
were defined, five of which were considered as PET viable
and 13 as PET nonviable, as assessed with NH3 and FDG
studies, according to previously established criteria (19,20).
MYOCARDIAL BLOOD FLOW. In regions with a PET-viable
pattern, as assessed with NH3 and FDG at five days, acetate
blood flow values were not significantly different from values
obtained in normal volunteers (0.57 6 0.12 vs. 0.64 6 0.11
ml/g per min, p 5 NS). In regions with a PET-nonviable
pattern, as assessed with NH3 and FDG at five days,
myocardial blood flow, as measured with acetate in the early
stage, was decreased (0.43 6 0.10 ml/g per min, p , 0.05
vs. volunteers). Blood flow measured with acetate in remote
areas was significantly higher than those values in the
patients’ PET-viable and PET-nonviable areas and those
values obtained in normal volunteers (0.83 6 0.18 ml/g per
min, p , 0.05 vs. volunteers and patients’ PET-viable or
-nonviable regions).
MYOCARDIAL OXYGEN CONSUMPTION (AS ESTIMATED BY
K2). The k2 values in PET-viable areas (0.073 6 0.02/min)
and PET-nonviable areas (0.076 6 0.02/min) were similar
(p 5 NS). Moreover, k2 values in those areas were slightly
lower but not statistically significantly different from k2
values in patients’ remote areas (0.099 6 0.03/min) and in
normal volunteers (0.096 6 0.03/min) (p 5 NS).
Functional follow-up. For functional follow-up, global
ejection fractions were measured five days and three months
after the infarction, using nuclear angiography. At five days,
a poor linear correlation was observed between LV ejection
fraction and measurements of flow (acetate: r 5 0.4, p 5
0.055; NH3: r 5 0.5, p , 0.05) and metabolic indexes
(acetate: r 5 0.5, p , 0.05; FDG: r 5 0.34, p 5 NS) in the
infarct area.
At follow-up, linear regression analysis revealed a fairly
poor correlation between global LV ejection fraction at
three months and the early flow index measurements with
acetate (r 5 0.6, p , 0.01) and NH3 in the infarct area (r 5
0.45, p , 0.05). Similarly, a poor correlation was observed
between LV ejection fraction at three months and the
glucose metabolic index in the infarct area five days after the
acute event (r 5 0.5, p , 0.05). However, a good linear
correlation was observed between global LV function at
three months and the early measurements of the acetate
metabolic index in the infarct zone (r 5 0.8, p , 0.0001)
(Fig. 1). No significant correlation was found between
changes in ejection fraction between five days and three
months and the early acetate, NH3 or FDG measurements
in reperfused myocardium (p 5 NS).
For further statistical analysis, the patients were classified
into two groups: group 1 5 patients with normal LV
function at five days or significant improvement of
LV function at follow-up; group 2 5 patients with impaired
LV function at five days and without recovery of LV
function. Multivariate analysis revealed that oxidative me-
tabolism in reperfused myocardium was the only significant
predictor for recovery of LV function at three months in this
study group (p , 0.05 vs. NH3 uptake and FDG uptake)
(Fig. 2). Significantly higher values of oxidative metabolism
were found in reperfused myocardium in group 1 (0.83 6
0.12) compared with group 2 (0.56 6 0.15, p , 0.01). The
FDG uptake in the infarct area also tended to be higher in
group 1 (0.67 6 0.23) compared with group 2 (0.48 6 0.12,
p 5 NS), but this difference did not reach statistical
significance. No significant difference was found between
the two groups in terms of myocardial blood flow.
DISCUSSION
Myocardial blood flow and metabolism. In this study,
only patients with TIMI flow grade 3 reperfused MI were
studied. Interestingly, persistent and relatively severe flow
reductions were observed in the infarct area of several
patients, despite successful thrombolysis early after the onset
of acute symptoms. This “no reflow” phenomenon has been
described previously and was attributed to a disrupted
microvasculature (9). Absolute blood flow in the remote
areas of the patients with infarcts was significantly higher
than that in normal volunteers. However, oxidative metab-
olism, which is indicative of myocardial oxygen demand,
was not enhanced significantly. Therefore, the improved
blood flow in remote myocardium probably did not result in
a compensatory improved contractile function.
Acetate kinetic properties allow noninvasive characteriza-
tion of regional myocardial oxygen consumption in ischemic
myocardium (21). In a study by Gropler et al. (22), marked
reduction in FDG activity, with preservation of oxidative
metabolism, was observed in viable myocardial tissue after
acute MI. It was postulated that this pattern might be more
common in patients receiving thrombolytic therapy. In our
study, which was performed exclusively in patients under-
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going successful thrombolysis, similar observations were
made. Oxygen consumption values in PET-viable areas
were not statistically different from those values in PET-
nonviable areas, hereby challenging the classic “PET viable”
and “PET nonviable” classification, as assessed with NH3
and FDG in the early stage after reperfusion therapy. In the
acute and subacute period after MI, NH3 and FDG might
not be the most accurate tracers to determine whether
functional recovery will occur. In a previous study, signifi-
cant improvement of flow values, as measured with NH3 at
five days and three months after MI, have been reported in
TIMI flow grade 3 reperfused MI (23). One hypothesis for
Figure 1. Linear regression plots comparing ejection fractions (EF) at five days and three months with the acetate perfusion index, acetate metabolic index,
NH3 perfusion index and FDG metabolic index. glob. EF 5d 5 global ejection fraction at five days (%); glob. EF 3m 5 global ejection fraction at three
months (%); fdg 5 fluorine-18–fluorodeoxyglucose (FDG); perf. 5 perfusion; met. 5 metabolic; nh3 5 ammonia (NH3).
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this phenomenon was an underestimation of flow by NH3
shortly after the infarction, due to attenuated glutamine
synthetase activity in the first days after the acute event (24).
An alternative explanation would be development and
recruitment of collateral vessels resulting in increased per-
fusion levels of the infarct area at later time points. As for
FDG uptake, decreased glucose metabolic rates with pres-
ervation of oxygen consumption have been observed after
ischemia in acute animal experiments (25). It is possible that
early after infarction, a switch to other substrates occurs in
viable postischemic myocardium. This would, of course,
hamper the prognostic role of FDG early after MI. This
hypothesis is also sustained by our results, which show a
poor linear correlation between oxidative metabolism and
FDG uptake. Alternatively, this poor correlation might just
be attributable to the known physiologic variability of
glucose utilization. However, this is not likely, because the
use of a metabolic index results in a normalization of the
data, thereby reducing interpatient variability.
Myocardial function. In patients with chronic coronary
artery disease, combined measurements of NH3 and FDG
uptake have excellent predictive value for functional recov-
ery after revascularization (26,27). The extent to which
functional recovery occurs after subsequent revascularization
can also be predicted by quantification of regional oxidative
metabolism (28). In the setting of acute MI, oxidative
metabolism appears to be a more accurate predictor of
myocardial function at follow-up, compared with glucose
metabolism estimated with FDG (29,30). Multivariate
analysis in this study group revealed that oxidative metab-
olism was the only significant predictor for recovery of LV
function at three months. The predictive value of acetate
was also confirmed by the good linear relation that was
observed between the early (within 24 h) acetate measure-
ments and ejection fractions at three months.
Another interesting finding was the presence of normal or
near-normal ejection fractions in several patients five days
after the acute event. This can be related to the early and
documented successful reperfusion therapy. Alternatively,
distal occlusion of a coronary artery, resulting in a small
infarction, would be a possible explanation. Other patients
revealed abnormal LV function at five days, probably due to
either persistent stunning or irreversible damage at that
time.
Study limitations. Because of the stringent protocol in
severely compromised cardiovascular patients, only 18 pa-
tients were included. It is possible that because this study
group was relatively small, both FDG and NH3 failed to
demonstrate a significant predictive value for LV function at
follow-up. In larger groups, flow values in the infarct-
related territory have been shown to have considerable
predictive value for recovery of LV function (9,31). How-
ever, even in this limited group, statistically significant
results could be obtained regarding the prognostic role of
acetate.
Conclusions. From this study, it can be concluded that
acetate measurements of oxidative metabolism in reperfused
myocardium obtained early after successful thrombolysis
contain important prognostic information on the recovery of
LV function. Recovery of oxidative metabolism appears to
be present early (within 24 h) after recanalization and seems
to be an excellent predictor of LV function at follow-up.
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